_version_ 1785090439694516224
author Roddie, Claire
Sandhu, Karamjeet
Tholouli, Eleni
Shaughnessy, Paul
Barba Suñol, Pere
Nuno Direito de Morais Guerreiro, Manuel
Abedi, Mehrdad
Bishop, Michael
Yared, Jean
Ghobadi, Armin
Yallop, Deborah
Logan, Aaron
Amer, Beitinjaneh
Pantin, Jeremy
Arellano, Martha L
Chaganti, Sridhar
Malladi, Ram
Menne, Tobias
Escamilla, Virginia
Hodby, Katharine
Gundabolu, Krishna
Mountjoy, Luke
Odwyer, Kristen
Abedin, Sameem
Alkhateeb, Hassan
Shah, Bijal
Basilico, Silvia
Cluxton, Deborah
Dawes, Joanna
Lao-Sirieix, Pierre
Raymond, Meera
Shang, Justin
Hu, Yanqing
Pittari, Gianfranco
Saxena, Kapil
Brugger, Wolfram
Zhang, Y
Pule, Martin
Park, Daniel
De Angelo, Daniel
Jabbour, Elias
author_facet Roddie, Claire
Sandhu, Karamjeet
Tholouli, Eleni
Shaughnessy, Paul
Barba Suñol, Pere
Nuno Direito de Morais Guerreiro, Manuel
Abedi, Mehrdad
Bishop, Michael
Yared, Jean
Ghobadi, Armin
Yallop, Deborah
Logan, Aaron
Amer, Beitinjaneh
Pantin, Jeremy
Arellano, Martha L
Chaganti, Sridhar
Malladi, Ram
Menne, Tobias
Escamilla, Virginia
Hodby, Katharine
Gundabolu, Krishna
Mountjoy, Luke
Odwyer, Kristen
Abedin, Sameem
Alkhateeb, Hassan
Shah, Bijal
Basilico, Silvia
Cluxton, Deborah
Dawes, Joanna
Lao-Sirieix, Pierre
Raymond, Meera
Shang, Justin
Hu, Yanqing
Pittari, Gianfranco
Saxena, Kapil
Brugger, Wolfram
Zhang, Y
Pule, Martin
Park, Daniel
De Angelo, Daniel
Jabbour, Elias
author_sort Roddie, Claire
collection PubMed
description
format Online
Article
Text
id pubmed-10428320
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283202023-08-17 S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY Roddie, Claire Sandhu, Karamjeet Tholouli, Eleni Shaughnessy, Paul Barba Suñol, Pere Nuno Direito de Morais Guerreiro, Manuel Abedi, Mehrdad Bishop, Michael Yared, Jean Ghobadi, Armin Yallop, Deborah Logan, Aaron Amer, Beitinjaneh Pantin, Jeremy Arellano, Martha L Chaganti, Sridhar Malladi, Ram Menne, Tobias Escamilla, Virginia Hodby, Katharine Gundabolu, Krishna Mountjoy, Luke Odwyer, Kristen Abedin, Sameem Alkhateeb, Hassan Shah, Bijal Basilico, Silvia Cluxton, Deborah Dawes, Joanna Lao-Sirieix, Pierre Raymond, Meera Shang, Justin Hu, Yanqing Pittari, Gianfranco Saxena, Kapil Brugger, Wolfram Zhang, Y Pule, Martin Park, Daniel De Angelo, Daniel Jabbour, Elias Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428320/ http://dx.doi.org/10.1097/01.HS9.0000967960.99850.6d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Roddie, Claire
Sandhu, Karamjeet
Tholouli, Eleni
Shaughnessy, Paul
Barba Suñol, Pere
Nuno Direito de Morais Guerreiro, Manuel
Abedi, Mehrdad
Bishop, Michael
Yared, Jean
Ghobadi, Armin
Yallop, Deborah
Logan, Aaron
Amer, Beitinjaneh
Pantin, Jeremy
Arellano, Martha L
Chaganti, Sridhar
Malladi, Ram
Menne, Tobias
Escamilla, Virginia
Hodby, Katharine
Gundabolu, Krishna
Mountjoy, Luke
Odwyer, Kristen
Abedin, Sameem
Alkhateeb, Hassan
Shah, Bijal
Basilico, Silvia
Cluxton, Deborah
Dawes, Joanna
Lao-Sirieix, Pierre
Raymond, Meera
Shang, Justin
Hu, Yanqing
Pittari, Gianfranco
Saxena, Kapil
Brugger, Wolfram
Zhang, Y
Pule, Martin
Park, Daniel
De Angelo, Daniel
Jabbour, Elias
S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
title S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
title_full S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
title_fullStr S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
title_full_unstemmed S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
title_short S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
title_sort s262: safety and efficacy of obecabtagene autoleucel (obe-cel), a fast-off rate cd19 car in relapsed/refractory adult b-cell acute lymphoblastic leukaemia:top line results of the pivotal felix study
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428320/
http://dx.doi.org/10.1097/01.HS9.0000967960.99850.6d
work_keys_str_mv AT roddieclaire s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT sandhukaramjeet s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT tholoulieleni s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT shaughnessypaul s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT barbasunolpere s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT nunodireitodemoraisguerreiromanuel s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT abedimehrdad s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT bishopmichael s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT yaredjean s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT ghobadiarmin s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT yallopdeborah s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT loganaaron s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT amerbeitinjaneh s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT pantinjeremy s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT arellanomarthal s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT chagantisridhar s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT malladiram s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT mennetobias s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT escamillavirginia s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT hodbykatharine s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT gundabolukrishna s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT mountjoyluke s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT odwyerkristen s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT abedinsameem s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT alkhateebhassan s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT shahbijal s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT basilicosilvia s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT cluxtondeborah s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT dawesjoanna s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT laosirieixpierre s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT raymondmeera s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT shangjustin s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT huyanqing s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT pittarigianfranco s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT saxenakapil s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT bruggerwolfram s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT zhangy s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT pulemartin s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT parkdaniel s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT deangelodaniel s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy
AT jabbourelias s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy